by in

PTS Diagnostics Introduces A1CNow® SELFCHECK Analyzer

PTS Diagnostics Introduces A1CNow® SELFCHECK Analyzer

Medical device provides at-home A1c monitoring in less than 5 minutes

Indianapolis, IN– Sept. 3, 2014 – Consumers now have the ability to test their A1c from home in less than 5 minutes thanks to PTS Diagnostics’ introduction of the A1CNow SELFCHECK system.

A1CNow SELFCHECK is a consumer-friendly medical device that provides a fast, easy and accurate at-home testing method for obtaining HbA1c results. In just five minutes, people can get an idea of their 2- to 3-month average blood glucose control.

A1CNow SELFCHECK is now available for purchase online at www.a1cnowselfcheck.com.

“The A1CNow SELFCHECK system is an important tool for diabetes management,” said James Anderson, MD, PTS Diagnostics’ medical director. “People with diabetes who desire an at-home monitoring system to measure their A1c between physician office visits now have a simple way to aid their self-management. Consumers can know that the A1CNow SELFCHECK system provides accuracy comparable to a certified laboratory method.1.”

Robert Huffstodt, President and CEO of PTS Diagnostics, commented that the consumer product is essentially the same as the A1CNow+ system used by medical professionals. “A1CNow systems are trusted by medical professionals across the country,” Huffstodt said. “The A1CNow SELFCHECK system uses a very small blood sample from a simple fingerstick. The system is affordable, fast, easy-to-use, and requires no maintenance.”

The A1CNow SELFCHECK system comes in a convenient 2-test pack with the items the consumer needs to complete both tests (monitor, test cartridges, fingerstick lancets and blood collectors.)

“A scientific study has demonstrated that just a 1 percentage point reduction in a patient’s A1c level may reduce their risk of complications by up to 40 percent2,” said Dr. Anderson. “Many doctors would agree that when a person with diabetes regularly monitors their A1c levels, they tend to pay closer attention to their diet and, often times, lower the average glucose level in the blood. By regularly monitoring their A1c, a patient can better manage their diabetes.”

About PTS Diagnostics – PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products. The company is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim.

For more information, visit http://www.a1cnowselfcheck.com or contact Tom Wiser at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

1. NGSP Certificate September 1, 2014: ptsdiagnostics.com
2. Stratton IM, Adler Al, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ. 2000;321:405-412.
MKG001105 Rev.1 03/15